Chynna Broxton

Company: Spark Therapeutics, Inc.

Job title: Analytical Development Scientist

Seminars:

Advancing Residual DNA Characterization with A Multiplexed Digital PCR-Based Approach to Size Profiling 12:30 pm

Development of a dPCR assay for precise sizing of residual DNA in gene therapy products Analytical strategies to distinguish and quantify short vs long DNA fragments for improved quality assessments How expanded size characterization can support regulatory guidance and CMC filings beyond current standards.Read more

day: Conference Day Two - Bioassays & Molecular